4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001181431-14-006076
President and CEO acquired 210,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Anzalone Christopher Richard · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2014-02-06 | Grant or award : show line 1 in the form | +210,000 | 244,173 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2014-02-06 | Grant or award : show line 2 in the form Stock Options | +60,000 | 786,466 | D |
Loading xslF345X03/rrd402056.xml…